Keyphrases
Chemotherapy
100%
Epidermal Growth Factor
100%
Tumor-associated Macrophages
100%
Transcriptional Reprogramming
100%
Stabilin-1
100%
Cisplatin
36%
Endocytosis
27%
Patients with Breast Cancer
18%
Tumor Growth
9%
Recombinant
9%
Cancer Mortality
9%
Flow Cytometry
9%
Confocal Microscopy
9%
Macrophage Scavenger Receptor 1 (MSR1)
9%
Negative Regulator
9%
Tumor Microenvironment
9%
Chemotherapy-induced
9%
Transcriptome
9%
CHO Cells
9%
Immunomodulator
9%
Positive Regulator
9%
Differential Expression
9%
Synaptotagmin
9%
Transcriptional Program
9%
Whole Transcriptome Sequencing
9%
Tumor Resistance
9%
Cancer Resistance
9%
Resistance to Chemotherapy
9%
Platinum Therapy
9%
Endocytic Trafficking
9%
Metastatic Relapse
9%
Functional Program
9%
Endocytic Uptake
9%
Platinum Agents
9%
Positive Stimulation
9%
Clearance Function
9%
Synergistic Action
9%
Cytostatic Agents
9%
Mode Suppression
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Chemotherapy
100%
Epidermal Growth Factor
100%
Cisplatin
36%
Malignant Neoplasm
18%
Breast Cancer
18%
Transcriptome
18%
Tumor Growth
9%
Confocal Microscopy
9%
Scavenger Receptor
9%
Flow Cytometry
9%
Antiinfective Agent
9%
Cytostatic Agent
9%
Tumor Microenvironment
9%
Immunomodulating Agent
9%
Therapy Resistance
9%
Tumor Resistance
9%
Synaptotagmin
9%
Biochemistry, Genetics and Molecular Biology
Reprogramming
100%
Epidermal Growth Factor
100%
Tumor-Associated Macrophage
100%
Cisplatin
36%
Endocytosis
27%
Tumor Progression
9%
Next Generation Sequencing
9%
Internalization
9%
Scavenger Receptor
9%
Confocal Microscopy
9%
RNA Sequencing
9%
Synaptotagmin
9%
Flow Cytometry
9%
Transcriptome
9%
Immunology and Microbiology
Tumor-Associated Macrophage
100%
Epidermal Growth Factor
100%
Endocytosis
27%
Next Generation Sequencing
9%
Scavenger Receptor
9%
Internalization
9%
Transcriptome
9%
RNA Sequencing
9%
Immunomodulating Drugs
9%
Confocal Microscopy
9%